Clinical laboratory · 2025
The Unusual Actinotigum schaalii (Formerly Named Actinobaculum schaalii) Bacteremia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zheng Lu-Qing, Wang Qing-Yong
Аннотация
BACKGROUND: This study aimed to evaluate unusual case reports about Actinotigum schaalii (A. schaalii) bacteremia patients in the past 20 years.
METHODS: A retrospective review of A. schaalii bacteremia patients collected from MEDLINE between January 2005 and November 2024.
RESULTS: Of 34 cases, the identification (ID) of A. schaalii for clinical samples included blood (n = 34), urine (n = 6), valve (n = 1), and biopsy (n = 1). Polymicrobial infections were 32.4% (n = 11 out of 34) in this study. Antimicrobial susceptibility tests (ASTs) were performed in most cases. The A. schaalii isolates were sensitive to penicillin, β-lactam combination agent, lincosamide, tetracycline, nitrofuran, cephem, carbapenem, oxazolidinone, ansamycin, macrolide, and glycylcycline; but resistant to fluoroquinolone, nitroimidazole, aminoglycoside, and folate pathway antagonists.
CONCLUSIONS: Microbiologists should perform the correct ID and suitable AST of the potentially invasive A. schaalii to help clinicians obtain the appropriate antimicrobial coverage for serious systemic infections.
METHODS: A retrospective review of A. schaalii bacteremia patients collected from MEDLINE between January 2005 and November 2024.
RESULTS: Of 34 cases, the identification (ID) of A. schaalii for clinical samples included blood (n = 34), urine (n = 6), valve (n = 1), and biopsy (n = 1). Polymicrobial infections were 32.4% (n = 11 out of 34) in this study. Antimicrobial susceptibility tests (ASTs) were performed in most cases. The A. schaalii isolates were sensitive to penicillin, β-lactam combination agent, lincosamide, tetracycline, nitrofuran, cephem, carbapenem, oxazolidinone, ansamycin, macrolide, and glycylcycline; but resistant to fluoroquinolone, nitroimidazole, aminoglycoside, and folate pathway antagonists.
CONCLUSIONS: Microbiologists should perform the correct ID and suitable AST of the potentially invasive A. schaalii to help clinicians obtain the appropriate antimicrobial coverage for serious systemic infections.